Tadamasa Goto’s FBI Intelligence Deal and UCLA Liver Transplant was a 2001 exchange in which a powerful Japanese organized-crime figure offered intelligence in return for help entering the United States for a liver transplant. Goto received the visa and the operation at UCLA; the FBI, according to the later reconstruction, received only a fraction of the information he had promised. The episode joined two systems with very different responsibilities: law enforcement seeking intelligence and a transplant system allocating scarce organs. What remained uncertain—what American authorities and medical staff knew, and where the treatment money came from—became central to the story’s public significance.

The Approach and the Exchange

In January or February 2001, doctors at Showa University told Goto that without a liver transplant soon he would die. He had hepatitis C and a heart condition, and was considered a very unlikely transplant candidate in Japan. The urgency of his medical situation set the terms for what followed: Goto wanted access to treatment in the United States, where he had arranged a possible path to a transplant at UCLA.

In April, Goto approached the FBI through Hoshi Hitoshi, a former fixer for Nobusuke Kishi with influential political connections. Kishi relayed the offer. The FBI wanted information about senior yakuza figures because the National Police Agency had refused to share such information, citing privacy issues. Without it, the FBI had difficulty monitoring yakuza activity in the United States.

Goto offered a comprehensive account of Yamaguchi-gumi members, associated front companies and financial institutions, as well as information about North Korean activity. In exchange, he sought a United States visa so that he could undergo the transplant at UCLA. The visa did not itself provide medical treatment: the FBI helped open the door by pressing U.S. Immigration and Customs Enforcement to grant it, and UCLA carried out the operation. The account describes the practical bargain as access in return for intelligence, not an FBI role in choosing or providing a liver.

Transplant and Unequal Outcomes

The operation took place on July 5, 2001. Goto supplied the FBI with only a fraction of the information he had promised. After receiving the transplant, he returned to Japan before the end of the year and did not speak to the FBI again. The arrangement therefore produced sharply different results for its participants: Goto obtained the medical access he needed, while the intelligence operation fell short of its intended return. The later account presents the deal as a major success for Goto and a limited one for the FBI.

The difference mattered beyond the two parties. Japan had a stringent transplant system and few donors; people in need of organs often left the country or died waiting. Goto’s treatment in the United States prompted the narrator to ask why Japanese criminals might receive transplants while law-abiding Americans did not. That question raised concerns about fairness, but it did not establish that the transplant itself had been improperly allocated. The account distinguishes the scarcity and ethical stakes from any claim that the operation violated medical rules.

The treatment of Goto and three other Japanese patients with yakuza ties brought separate questions about clinical duty and public accountability into view. UCLA and Dr. Busuttil said that they did not make moral judgments about patients and treated them according to medical need. It had not been proven that either knew of the patients’ criminal affiliations at the time of the transplants. A review by the U.S. Centers for Medicare and Medicaid Services and UCLA found no evidence of improper conduct, according to the Los Angeles Times. Yet the review did not settle what UCLA or its staff knew about the patients’ ties, or when they knew it. The account also leaves unresolved whether money paid for treatment came, in any instance, from criminal activity.

Reconstructing the Deal

The transaction became a story years after the surgery. In November 2006, a Goto-gumi member whom Goto’s harsh internal discipline had alienated told Jake Adelstein that the FBI had let Goto enter the United States. The source provided approximate dates and identified Jim Moynihan, the legal attaché at the U.S. Embassy in Japan, as the person who arranged it. Moynihan was also Adelstein’s friend and mentor, which made the disclosure personally difficult as well as professionally consequential.

Adelstein pursued corroboration rather than relying on the disclosure alone. A large body of data, conversations with a source in the U.S. Justice Department, and sources in Japanese police and underworld circles helped him assemble the chronology and the terms of the exchange. In December 2006, he asked Moynihan about making a deal with Goto. The later account presents the information as a reconstruction from multiple sources, while still marking some questions—particularly what UCLA knew—as unanswered.

Publication, Risk, and Aftermath

Adelstein first developed the material for a book and tried to place the story in a Japanese weekly magazine, which rejected it. He later decided to write the account in English. His initial effort to publish through the Foreign Correspondents’ Club of Japan newspaper also failed: an editor’s accidentally forwarded memo described the claim as difficult to believe. These refusals did not disprove the reporting, but they delayed its public appearance and intensified the pressure surrounding it.

As the story became more dangerous to pursue, Adelstein was told that Goto had decided to have him killed if Goto were found guilty. On March 5, 2008, Adelstein was placed under police protection. The reporting thus carried consequences beyond the transplant controversy: revealing how Goto obtained entry to the United States also exposed the sensitive intelligence exchange behind it and placed the reporter at risk.

The account connects publication of the material to a later organizational consequence, but does not reduce that consequence to a simple, immediate cause. In October 2008, Goto was expelled from the Yamaguchi-gumi. Police told Adelstein that publication of Heisei Japan Taboo Compendium 2008 had been the tipping point; Goto’s associates were also suspended, expelled, or banished, and the Goto-gumi split into two crime families. The transplant deal therefore came to signify more than a secret route to medical care. Its eventual exposure challenged the presumed boundary between criminal organizations, intelligence agencies, medical institutions, and the public’s right to scrutinize how scarce treatment and cross-border cooperation are obtained.